Clinical perspective
Spondyloarthritis
Use the family concept to recognise connections, then return to the specific phenotype, evidence and decision. Classification, diagnosis and treatment eligibility are distinct tasks.
01 · Clinical review
Diagnosis & classification
Use criteria in their intended population and preserve the uncertainty in each input. A calculated classification result is not an individual diagnostic probability.
Read clinical review →02 · Clinical review
Imaging in context
An imaging label gains meaning from the lesion definition, acquisition quality, distribution and clinical setting. Avoid translating a single finding directly into a diagnosis.
Read clinical review →03 · Clinical review
Treatment across domains
Choose a strategy for the active phenotype and the whole person. Evidence for one domain, a guideline recommendation and a local authorised indication are not interchangeable.
Read clinical review →Clinical collection · English · Professional reading
Radiographic axial spondyloarthritis
Independent clinical articles on diagnostic reasoning, sacroiliac grading, MRI and CT, disease activity, treatment selection, nonresponse, tapering and the vulnerable ankylosed spine.
Explore the r-axSpA clinical collection →Clinical chapter · EN · Professional access
Non-radiographic axial spondyloarthritis
Diagnostic reasoning, imaging, prognosis and treatment across 11 sections, with five integrated clinical cases and printable professional worksheets.
Read the nr-axSpA clinical chapterDisease-specific clinical collection · EN
Psoriatic arthritis
Phenotyping across domains and difficult diagnostic boundaries, with links to the PsA patient companions.
Explore the PsA professional collection →Disease-specific clinical collection · EN
Reactive arthritis
From the first hot joint after infection to persistent disease: diagnostic reasoning, infection care, the antibiotic controversy and a treatment evidence map. Includes clinical decision scenarios and patient explanations in four languages.
Explore the reactive arthritis clinical module →Disease-specific clinical collection · EN
IBD-associated spondyloarthritis
Professional Essentials and clinical chapters on finding disease in both directions, choosing therapy across organs and assessing discordant responses.
Explore the IBD-associated SpA clinical collection →Disease-specific clinical collection · EN
Peripheral / undifferentiated spondyloarthritis
Professional Essentials and clinical chapters on phenotype, diagnostic uncertainty, treatment evidence and longitudinal reassessment.
Explore the peripheral / undifferentiated SpA clinical collection →Disease-specific clinical collection · EN
Juvenile-onset spondyloarthritis
Professional Essentials, classification boundaries and juvenile-onset disease in adult care: reconstructing the childhood history and keeping transition continuous.
Explore the juvenile SpA clinical collection →Core principles across the SpA family
Two maps, four clinical statements
Describe the named disease or associated context separately from the active musculoskeletal and extra-musculoskeletal domains. Add the degree of diagnostic confidence and distinguish current inflammation from damage and other symptom generators. ‘PsA with peripheral synovitis, dactylitis and suspected axial involvement’ is more informative than placing PsA entirely under peripheral SpA. ‘Non-radiographic’ is an imaging category, not a measure of impact or a mandatory stage in a linear progression.
Shared pathways do not imply interchangeable treatment
Enthesis-related pathology, synovitis, osteitis and bone remodelling connect these disorders, with contributions from genetic susceptibility, biomechanical factors and immune pathways. The TNF/IL-17/IL-23 framework is useful but incomplete. Biological plausibility and efficacy in skin or peripheral PsA do not establish efficacy in established axial SpA. Use clinical trial populations and domain-specific outcomes to test mechanistic assumptions.
Keep axial PsA visible
PsA may have axial involvement, peripheral involvement or both. Definitions, imaging patterns and ascertainment remain important sources of heterogeneity. The international AXIS study is relevant to phenotype description; it is not permission to replace clinical assessment with the ASAS axial classification algorithm in every patient with psoriasis and back pain. Check whether evidence concerns axSpA with psoriasis, axial PsA or a post hoc subgroup defined by symptoms.
Assess what remains active
For axSpA, ASDAS provides a disease-activity framework with clinical assessment; BASDAI captures patient-reported burden but is not an objective inflammation test. For PsA, joint-focused instruments such as DAPSA do not fully represent skin, enthesitis, dactylitis or axial disease. Minimal disease activity is a multidomain state, yet individual domains still need inspection. Persistent symptoms require evaluation of inflammation, structural limitation, adherence, comorbidity and pain mechanisms.
Three short reasoning prompts
A patient with psoriasis and heel tenderness needs assessment for enthesitis and mechanical explanations before the skin diagnosis is used as an anchor. A patient with established axSpA and high pain despite a stable examination needs a search for active disease and additional contributors before escalation. A patient with bowel remission and inflammatory axial symptoms still requires an axial assessment; control of one organ does not establish control of another.
Interactive explorer · EN
Classification Explorer
Explore the family map, criteria and sacroiliitis grading. Professional tool in English.
Select a section inside the tool to explore. Classification criteria do not establish an individual diagnosis.
CASCADE · Professional learning · EN
From IL-23 biology to a defensible treatment plan
Explore the receptor mechanism, distinguish psoriasis evidence from PsA evidence, and work through George’s uncertain joint symptoms.
Patient education
Clear explanations to share
Shared features, diagnosis, treatment and daily life, with a direct route into each language.
Sources & further reading
- ASAS consensus on the nomenclature of axial spondyloarthritis (2024)
- ASAS–EULAR axSpA management recommendations: 2022 update
- EULAR PsA pharmacological recommendations: 2023 update, published 2024
- GRAPPA treatment recommendations 2021, published 2022
- International AXIS study: axial involvement in PsA (2026)
- EULAR recommendations for fatigue in inflammatory rheumatic diseases (2023)
Interactive clinical reasoning · English
nr-axSpA · Professional quizzes
Apply the clinical chapter to diagnosis, imaging, prognosis, treatment and evidence. Quiz descriptions are open. Quizzes marked Open demo are available without an account; other full quizzes require professional access.
Below the Line Is Not “Early”
Radiographic category, symptom duration and disease burden.
Explore the quiz →A Referral Is Not a Verdict
Inflammatory back pain, HLA-B27, CRP and a reviewable working diagnosis.
Explore the quiz →Name the Joint, Name the Sequence
Dedicated SIJ MRI, structural lesions, reporting and the medication context.
Explore the quiz →Bright, but Whose?
Postpartum and loading changes, OCI, fracture and infection on SIJ MRI.
Explore the quiz →Progression Is One Outcome
Cohort denominators, risk factors and remission without an invented personal percentage.
Explore the quiz →Two NSAIDs Are a Trial, Not a Sentence
NSAID trials, objective inflammation and the move to advanced therapy.
Explore the quiz →The Eye and the Gut Choose First
Uveitis, IBD, response assessment and a reasoned treatment switch.
Explore the quiz →Change Is Not State
ASDAS response versus disease state, monitoring and tapering.
Explore the quiz →Plan Before the Positive Test
Conception, pregnancy, postpartum care and the infant’s vaccine plan.
Explore the quiz →Read the Entry Criteria
Trial populations, endpoints, cross-trial comparisons and JAK safety.
Explore the quiz →Open demo
Two Pains, One Patient
When the score stays high and the inflammation does not.
Explore the quiz →Bridging Is a Shape
Spinal findings, CT and anatomy: ask the structural question before the next scan.
Explore the quiz →Open demo
Now, Not Next Month
Safety boundaries in a patient who already has a diagnosis.
Explore the quiz →Write It So It Can Be Revised
Requests, reports and assessments that the next clinician can actually use.
Explore the quiz →Remission — Which Kind?
Feeling well, low activity, remission on treatment and after it: four different statements.
Explore the quiz →Open demo
A Difference Is Not a Test
Anti-CD74, genetic susceptibility, response signatures and the intended use of a biomarker.
Open the demo quiz →A Precise Number Is Not a Validated One
Faster MRI, synthetic CT, AI validation, flare prediction and the limits of a precise probability.
Explore the quiz →Open demo
Promising Is Not Proven
Sonelokimab, ERAP1, negative trials and the evidence needed before adopting an innovation.
Open the demo quiz →Open demo
The Wrong Scan and the Gut
Dedicated sacroiliac imaging, Crohn’s disease, treatment selection and separate axial, bowel and skin outcomes.
Open the demo quiz →A Taper Is a Plan, Not a Countdown
Certolizumab schedules, sustained control, a shared taper and flare plan, and radiographic category changes.
Explore the quiz →Ready Is Not the Same as Waiting
Rehabilitation, screening, vaccines and drug-specific risks: preparation that runs alongside treatment.
Explore the quiz →Difficult Is Not Refractory
After several drugs: drug levels, above-label dosing, dual therapy and the reason for each change.
Explore the quiz →“Still Tired” Is Not a Measurement
Fatigue, function, follow-up intervals and drug-specific safety: what a low score leaves out.
Explore the quiz →Pregnancy Is Not a Treatment
Preconception planning, delivery, the postpartum restart, breastfeeding and the partner’s medication.
Explore the quiz →Open demo
Quiet Is Not Gone
Juvenile-onset SpA at transfer: the original phenotype, pediatric MRI and a handover that keeps treatment going.
Open the demo quiz →CASCADE · Interactive clinical learning
Maria’s next treatment decision
Recurrent joint and skin symptoms: explore TYK2 signaling, critique a simulated trial and complete the original interactive case.
Open CSC-001 →